SCHEMBL7051744

SCHEMBL7051744

COCc1cc2c(N3CCN(C(C=O)c4ccccc4)CC3)ncnc2s1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.53
TSHR P16473 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
MAPT P10636 2/20 0.53
TP53 P04637 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
MEN1 O00255 7/20 0.50
P2RY12 Q9H244 5/20 0.50
KMT2A Q03164 5/20 0.49
HRH4 Q9H3N8 1/20 0.46
ALDH1A1 P00352 5/20 0.44
POLB P06746 2/20 0.44
MAPK1 P28482 1/20 0.44
KDM4E B2RXH2 3/20 0.43
LMNA P02545 2/20 0.43
ACHE P22303 1/20 0.43
BACE1 P56817 1/20 0.43
AURKA O14965 1/20 0.43
RXFP1 Q9HBX9 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7048623 0.89 HTT (0.67) HTTTSHRSMN1; SMN2MAPTTP53
SCHEMBL7053533 0.88 HTT (0.56) HTTTSHRSMN1; SMN2MAPTTP53
SCHEMBL7046754 0.84 ALDH1A1 (0.48) HTTTSHRSMN1; SMN2MAPTTP53
SCHEMBL7051646 0.81 HRH4 (0.58) HTTTSHRSMN1; SMN2MAPTTP53
SCHEMBL7047529 0.80 HRH4 (0.57) HTTTSHRSMN1; SMN2MAPTTP53
SCHEMBL7050933 0.79 KDM4E (0.43) HTTTSHRSMN1; SMN2MAPTTP53
SCHEMBL7052745 0.77 MEN1 (0.66) HTTTSHRSMN1; SMN2MAPTTP53
SCHEMBL5849808 0.76 P2RY12 (0.80) HTTTSHRSMN1; SMN2MAPTTP53
SCHEMBL7054382 0.76 SMN1; SMN2 (0.51) HTTTSHRSMN1; SMN2MAPTTP53
SCHEMBL7048493 0.76 SMN1; SMN2 (0.51) HTTTSHRSMN1; SMN2MAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003022214-A2 PIPERAZINE AND HOMOPIPERAZINE COMPOUNDS MILLENNIUM PHARMACEUTICALS, INC. (US) 2003-03-20 WO disclosed